Articles about Product Safety

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

The New Standard in Oncology: Harvard’s CHIEF AI Achieves Unprecedented Accuracy in Cancer Diagnosis and Prognosis

Today 15:19 EST

Via TokenRing AI

Momentum in Healthcare and Banking to Persist in 2026 as AstraZeneca and Citigroup Lead the Charge

Today 14:29 EST

Via MarketMinute

IVF Cryo Calls for Higher Standards in Embryo and Egg Shipping

Today 13:16 EST

Via Get News

The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026

Today 11:44 EST

Via MarketMinute

The FDA Just Snubbed Corcept Therapeutics. Should You Buy the Dip in CORT Stock or Stay Far Away

Today 11:17 EST

Via Barchart.com

QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

Today 11:15 EST

Via NewMediaWire

QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

Today 11:15 EST

Via TheNewswire.com

Tesla (TSLA) in 2026: The AI Pivot and the ‘Delivery Hollow’ Challenge

Today 10:18 EST

Via PredictStreet

The RNAi Powerhouse: A Deep Dive into Alnylam Pharmaceuticals’ Path to the S&P 500

Today 9:59 EST

Via PredictStreet

Why Did Ironwood Pharmaceuticals Stock Skyrocket Today? ↗

Today 9:40 EST

Via Stocktwits

Outlook Therapeutics Tanks Over 60% On Another FDA Blow – Here’s How Retail Is Reacting ↗

Today 8:28 EST

Via Stocktwits

Outlook Therapeutics Stock Sinks After FDA Rejects Eye Drug Again ↗

Today 8:18 EST

Via Benzinga

PharmaTher CEO Publishes Letter to Shareholders

Today 8:00 EST

Via Newsfile

The Great Rebalancing: Thin Holiday Trading and Institutional Pivots Cap a Volatile 2025

January 01, 2026

Via MarketMinute

Impinj (PI) Rings in 2026 with 3% Momentum: Why Traders are Betting on the RAIN RFID Leader

January 01, 2026

Via MarketMinute

Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution

January 01, 2026

Via MarketMinute

Tesla 2026: From Automaker to AI Powerhouse—A Comprehensive Research Deep Dive

January 01, 2026

Via PredictStreet

WhiteSands Publishes New Resource on the Risks of Mixing Gabapentin and Tramadol

January 01, 2026

Via Press Advantage

2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky

December 31, 2025

Via StockStory

Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday ↗

December 31, 2025

Via The Motley Fool

Why Corcept Therapeutics Plummeted by 50% Today ↗

December 31, 2025

Via The Motley Fool

The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings

December 31, 2025

Via MarketMinute

FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026 ↗

December 31, 2025

Via MarketBeat

Why Corcept (CORT) Shares Are Falling Today

December 31, 2025

Via StockStory

Where Will Intuitive Surgical Be in 5 Years? ↗

December 31, 2025

Via The Motley Fool

What's Going On With Vanda Pharmaceuticals Stock Wednesday? ↗

December 31, 2025

Via Benzinga

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

Why Axsome Therapeutics Stock Rocketed Higher to End 2025 ↗

December 31, 2025

Via The Motley Fool

Axsome Therapeutics Stock Jumps After FDA Grants Priority Review For Alzheimer's Agitation Drug ↗

December 31, 2025

Via Investor's Business Daily

Language Scientific Explores How Pharmacovigilance Translation Supports Drug Safety Compliance

December 31, 2025

Via Press Advantage

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.